Drs. Miller, Wafapoor receive AAO achievement awards
January 1st 2007Las Vegas-Kevin M. Miller, MD, Kolokotrones Professor of Clinical Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, and Hussein Wafapoor, MD, of Retina Health Center, Fort Myers, FL, are among the physician recipients of the American Academy of Ophthalmology's (AAO) series of achievement awards.
SITA offers clinicians an other tool for visual field evaluation
December 15th 2006Ann Arbor, MI-The Swedish Interactive Threshold Algorithm (SITA) is one of the newer generations of perimetry basic detection devices used in glaucoma to evaluate visual fields. The others are short wavelength automated perimetry and frequency doubling technology. Emerging technologies include high-pass resolution perimetry and multifocal electrophysiological tests. Sayoko E. Moroi, MD, PhD, recently discussed SITA and how to use the test to the best advantage.
Bimanual vertical chop technique enhances phaco
December 15th 2006Surgical control in the anterior chamber is essential for performing effective phacoemulsification. The Sovereign system with WhiteStar technology (Advanced Medical Optics Inc.) features an innovative power modulation known as increased control and efficiency (ICE), which adds an initial kick to each millisecond pulse of ultrasound, increasing cutting power without increasing energy utilization.
Treatment of macular edema shows functional, structural benefits
December 15th 2006Fort Lauderdale, FL-An analysis of the correlation between macular thickness and visual acuity supports the concept that measurement of structural changes can provide valuable information about the nature of functional changes in the treatment of macular edema, said Julia A. Haller, MD, who spoke during the Association of Research in Vision and Ophthalmology annual meeting.
Limited evidence base exists to guide management of HSV keratitis
December 15th 2006Jacksonville, FL-Results of the Herpetic Eye Disease Studies (HEDS) have provided some guidance on the treatment of herpes simplex virus (HSV) keratitis, but questions remain about the management of these infections, said Thomas J. Liesegang, MD.
Sight-threatening keratitis seen in orthokeratology patient
December 15th 2006Fair Lawn, NJ-Acanthamoeba keratitis, a potentially sight-threatening condition, developed in a patient undergoing orthokeratology for the treatment of myopia. Osher Sebrow, MD, a private practitioner in Fair Lawn, NJ, described this case and the available management options.
Scleral spacing procedures investigated for presbyopia
December 15th 2006New York-The use of a scleral spacing procedure using PreView Scleral Implants (Refocus Group Inc.) appears to improve the technique to correct presbyopia. This revised technique seems to be a safe and effective method of improving near visual acuity without affecting distance visual acuity in emmetropic presbyopia, according to Barrie D. Soloway, MD, FACS.
AAO, APAO leaders tout strength in numbers
December 15th 2006Las Vegas-Leaders of the American Academy of Ophthalmology (AAO) and the Asia Pacific Academy of Ophthalmology (APAO) touted strength in numbers in remarks at the opening session of the first joint meeting of the two organizations in November.
Patients with milder keratoconus fare better after cataract surgery
December 15th 2006Philadelphia-After cataract surgery, patients with mild keratoconus may not need rigid gas-permeable (RGP) contact lenses for optimal vision, whereas those with moderate or severe disease might require these lenses, according to Nuthida Thebpatiphat, MD.
Intracorneal ring segments: more is not always better
December 15th 2006Coimbra, Portugal-Intracorneal rings (Intacs, Addition Technology) to correct keratoconus appear to produce better results when one ring segment is implanted inferiorly instead of having two segments implanted, one superiorly and one inferiorly, reported Joaquim N. Murta, MD, PhD.
Mapping the way to diagnosing ectasia
December 15th 2006Houston-Detecting corneal ectatic disorders has become easier because of new technology-such as the Pentacam (Oculus)-that removes artefacts and compensates for asphericity, and various topography and tomography maps that better pinpoint cases of keratoconus, according to Jack T. Holladay, MD, MSEE, FACS.
Surgeons describe approaches to endothelial disease
December 15th 2006A range of corneal pathologies and their treatment-including Descemet's stripping automated endothelial keratoplasty (DSAEK), Descemet's stripping with endothelial keratoplasty (DSEK), and preventing dislocations after endothelial keratoplasty (EK)-recently has captured the interests of ophthalmologists.
AMO recalls certain lots of contact lens solution
December 15th 2006Santa Ana, CA-Advanced Medical Optics Inc. (AMO) is voluntarily recalling 18 lots of its Complete MoisturePLUS multipurpose contact lens care solution distributed in the United States after water-borne bacteria were discovered in a small number of bottles, the company said.
AMO recalls contact lens care products
December 7th 2006Santa Ana, CA-Advanced Medical Optics Inc. (AMO) has announced a voluntary recall of 18 lots of its 12-ounce Complete MoisturePLUS multipurpose contact lens care solution and Active Packs distributed in the United States, because of an issue on two of four production lines at its manufacturing plant in China, the company said.
SOLX creates GMS certification program
December 5th 2006Boston-SOLX, the glaucoma division of OccuLogix Inc., has begun an international program to train and certify ophthalmologists in Europe and the Middle East in surgical implantation procedures using the company’s Gold Micro-Shunt (GMS) products to treat patients with glaucoma.
Heidelberg Engineering receives FDA clearance for spectral domain OCT
December 5th 2006Vista, CA, and Heidelberg, Germany-The FDA has granted clearance for Heidelberg Engineering GmbH’s Spectralis HRA+OCT, said to be the first commercially available spectral domain (sometimes called Fourier domain) optical coherence tomograph (OCT) combined with laser angiography. The company expects to begin shipping the product in mid-2007.
FDA requests more information from STAAR regarding toric ICL
December 5th 2006Monrovia, CA-The FDA Office of Device Evaluation has requested that STAAR Surgical Co. amend its submission for approval of its Visian TICL (toric implantable Collamer lens) to enable the agency to complete its review of the lens’ safety and effectiveness. The FDA indicated Nov. 20 that its evaluation of the amendment could extend the review period by up to 180 days after the information is submitted.
Lux Biosciences receives FDA clearance for uveitis drug
December 5th 2006Jersey City, NJ-Now that the 30-day waiting period has ended for the investigational new drug application filed by Lux Biosciences Inc. for the development of LX211 in uveitis, the company will begin three controlled, double-masked clinical trials of the next-generation calcineurin inhibitor in early 2007. The studies collectively will enroll more than 500 patients in North America and Europe.